Centene Financial Ratios
NYSE: CNCHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Centene ratio analysis
Centene earned a net margin of -3.4% in FY 2025, down from 2.0% a year earlier. Gross margin was 7.3% compared with a median of 95.4% over the prior 9 years. Return on equity reached -33.4%, meaning Centene generated -0.33 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.87 versus 0.70 the year before, and the current ratio was 1.10. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Centene financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | 9.74 | 14.99 | 39.62 | 36.14 | 19.24 | 19.48 | 25.12 | 21.56 | 16.52 |
| Price / sales | 0.11 | 0.20 | 0.26 | 0.33 | 0.38 | 0.31 | 0.34 | 0.37 | 0.36 | 0.22 |
| Price / book | 1.03 | 1.21 | 1.56 | 1.96 | 1.79 | 1.33 | 2.01 | 2.03 | 2.54 | 1.53 |
| Gross margin | 7.3% | 10.5% | 11.5% | 11.7% | 11.5% | 97.0% | 96.7% | 96.0% | 96.2% | 95.4% |
| Operating margin | -3.9% | 1.9% | 1.9% | 0.9% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% |
| Net margin | -3.4% | 2.0% | 1.8% | 0.8% | 1.1% | 1.6% | 1.8% | 1.5% | 1.7% | 1.4% |
| Free cash flow margin | 2.2% | -0.3% | 4.7% | 3.6% | 2.6% | 4.2% | 1.0% | 0.9% | 2.2% | 3.8% |
| Return on equity (ROE) | -33.4% | 12.5% | 10.5% | 5.0% | 5.0% | 7.0% | 10.5% | 8.2% | 12.1% | 9.5% |
| Return on assets (ROA) | -8.7% | 4.0% | 3.2% | 1.6% | 1.7% | 2.6% | 3.2% | 2.9% | 3.8% | 2.8% |
| Debt / equity | 0.87 | 0.70 | 0.69 | 0.75 | 0.70 | 0.65 | 1.09 | 0.61 | 0.69 | 0.79 |
| Current ratio | 1.10 | 1.11 | 1.11 | 1.06 | 1.11 | 1.08 | 1.57 | 1.00 | 0.93 | 0.97 |
| Revenue growth | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | 48.9% | 24.2% | 24.3% | 19.1% | 78.4% |
| EPS growth | -314.4% | 27.5% | 139.1% | -9.2% | -26.9% | -0.6% | 38.9% | -3.4% | 36.8% | -40.6% |